2007 JASN IMPACT FACTOR 7.111	HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP
advanced	CURRENT ISSUE	ARCHIVES	JASN Express	ONLINE SUBMISSION

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Giachelli, C. M. Search for Related Content PubMed PubMed Citation Articles by Giachelli, C. M.

Vascular Calcification: In Vitro Evidence for the Role of Inorganic Phosphate

Bioengineering Department, University of Washington, Seattle, Washington

Correspondence to Dr. Cecilia M. Giachelli, Bioengineering Department, Box 351720, University of Washington, Seattle WA 98195-1720. Phone: 206-543-0205; Fax: 206-616-9763;

ABSTRACT. Uremic patients are prone to widespread ectopic extraskeletal calcification resulting from an imbalance of systemic inorganic phosphate (Pi). There can be serious consequences of this process, particularly when it results in the calcification of the vasculature. A recent study examined the response of cultured human aortic smooth muscle cells to varying levels of extracellular Pi. Cells that were exposed to Pi levels similar to those seen in uremic patients (>1.4 mmol/L) showed dose-dependent increases in cell culture calcium deposition. The results of this study also defined the role of elevated phosphate in transforming the vascular phenotype of these cells to an osteogenic phenotype, such that a predisposition for calcification was created. Pi-induced changes included increased expression of the osteogenic markers osteocalcin and core-binding factor-1 genes, the latter of which is considered a "master gene" critical for osteoblast differentiation. These changes occur early after exposure to high phosphate levels and seem to be mediated by a sodium-dependent phosphate co-transporter, Pit-1 (Glvr-1). Calcification of vascular cells also seems to occur in the absence of a mineral imbalance but in the presence of platelet-derived growth factor, a potent atherogenic factor. Taken together, these data suggest that calcification of vascular cells can occur early in a phosphate-rich environment similar to that seen in patients with renal failure and in a platelet-derived growth factor–rich atherosclerotic region under normal phosphorus conditions. From a clinical viewpoint, it seems that early control or prevention of hyperphosphatemia may reduce coronary calcification and its associated morbidity and mortality for patients on dialysis. E-mail: ceci@u.washington.edu

This article has been cited by other articles:

				F. G. Graciolli, K. R. Neves, L. M. dos Reis, R. G. Graciolli, I. L. Noronha, R. M. A. Moyses, and V. Jorgetti Phosphorus overload and PTH induce aortic expression of Runx2 in experimental uraemia Nephrol. Dial. Transplant., December 15, 2008; (2008) gfn686v1. [Abstract] [Full Text] [PDF]

				V. Savica, G. Bellinghieri, and D. Santoro Phosphorus-Related Mechanisms of Vascular Calcification Arch Intern Med, November 26, 2007; 167(21): 2368 - 2368. [Full Text] [PDF]

				J. H. Ix, G. M. Chertow, M. G. Shlipak, V. M. Brandenburg, M. Ketteler, and M. A. Whooley Association of Fetuin-A With Mitral Annular Calcification and Aortic Stenosis Among Persons With Coronary Heart Disease: Data From the Heart and Soul Study Circulation, May 15, 2007; 115(19): 2533 - 2539. [Abstract] [Full Text] [PDF]

				P. Bottger, S. E. Hede, M. Grunnet, B. Hoyer, D. A. Klaerke, and L. Pedersen Characterization of transport mechanisms and determinants critical for Na+-dependent Pi symport of the PiT family paralogs human PiT1 and PiT2 Am J Physiol Cell Physiol, December 1, 2006; 291(6): C1377 - C1387. [Abstract] [Full Text] [PDF]

				R. C. Johnson, J. A. Leopold, and J. Loscalzo Vascular Calcification: Pathobiological Mechanisms and Clinical Implications Circ. Res., November 10, 2006; 99(10): 1044 - 1059. [Abstract] [Full Text] [PDF]

				X. Li, H.-Y. Yang, and C. M. Giachelli Role of the Sodium-Dependent Phosphate Cotransporter, Pit-1, in Vascular Smooth Muscle Cell Calcification Circ. Res., April 14, 2006; 98(7): 905 - 912. [Abstract] [Full Text] [PDF]

				M. Murshed, D. Harmey, J. L. Millan, M. D. McKee, and G. Karsenty Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone Genes & Dev., May 1, 2005; 19(9): 1093 - 1104. [Abstract] [Full Text] [PDF]

				P. Collin-Osdoby Regulation of Vascular Calcification by Osteoclast Regulatory Factors RANKL and Osteoprotegerin Circ. Res., November 26, 2004; 95(11): 1046 - 1057. [Abstract] [Full Text] [PDF]

				S. M. Moe and N. X. Chen Pathophysiology of Vascular Calcification in Chronic Kidney Disease Circ. Res., September 17, 2004; 95(6): 560 - 567. [Abstract] [Full Text] [PDF]

				G. M. London Cardiovascular Calcifications in Uremic Patients: Clinical Impact on Cardiovascular Function J. Am. Soc. Nephrol., September 1, 2003; 14(90004): S305 - 309. [Abstract] [Full Text]

				G. M. Chertow Slowing the Progression of Vascular Calcification in Hemodialysis J. Am. Soc. Nephrol., September 1, 2003; 14(90004): S310 - 314. [Abstract] [Full Text]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673